RECRUITING

Understanding Chronic Lymphocytic Leukemia

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.

Official Title

Understanding Chronic Lymphocytic Leukemia

Quick Facts

Study Start:1999-09-29
Study Completion:2032-09-29
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04028531

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * New and existing patients seen for treatment of monoclonal B-cell lymphocytosis
  2. * Any low grade lymphoproliferative disorder
  3. * Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Jennifer Brown, MD, PhD
CONTACT
617-582-8437
Jennifer_brown@dfci.harvard.edu

Principal Investigator

Jennifer Brown, MD,PhD
PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute

Study Locations (Sites)

Dana Farber Cancer Institute
Boston, Massachusetts, 02115
United States

Collaborators and Investigators

Sponsor: Dana-Farber Cancer Institute

  • Jennifer Brown, MD,PhD, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date1999-09-29
Study Completion Date2032-09-29

Study Record Updates

Study Start Date1999-09-29
Study Completion Date2032-09-29

Terms related to this study

Keywords Provided by Researchers

  • Chronic Lymphocytic Leukemia

Additional Relevant MeSH Terms

  • Chronic Lymphocytic Leukemia